Chemours sales down across the board in Q2

By Myles McCormick
Published: Tuesday, 09 August 2016

The chemicals producer reported weaker revenue figures across its titanium dioxide and fluorochemicals divisions, though a cost cutting programme meant its bottom line saw no decline. The company also said it will hike its TiO2 prices from September.

NYSE-listed The Chemours Co. recorded another quarter of lower year-on-year (y-o-y) revenues for Q2 2016.

Net sales for the Delaware, US-based titanium dioxide (TiO2) and fluorochemicals producer fell 8% to $1.508bn. The company’s net loss figure was even y-o-y at $18m, however, partially attributable to a programme of cost reduction....

This is a preview of the full article

Our market news and price data is reserved for registered users only.

Current customer? Login now

All of our industrial minerals price data and news is now available only through our new platform. Learn more about the intelligence we offer by visiting our Fastmarkets flagship website. If you are familiar with our reliable and trusted intelligence, fill out a request a quote form today to hear from our friendly sales staff who will create a custom license for you.


Interested in lithium prices? We now offer lithium prices and coverage free for reference. Click here to read all about it.

Interested in the wider electrification market?
Join our growing community of participants who want to learn more about electrification and how this market is developing.